Effects of bone-targeted agents on cancer progression and mortality.

Coleman, Robert

Effects of bone-targeted agents on cancer progression and mortality. [electronic resource] - Journal of the National Cancer Institute Jul 2012 - 1059-67 p. digital

Publication Type: Journal Article; Review

1460-2105

10.1093/jnci/djs263 doi


Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antineoplastic Agents--pharmacology
Bone Density Conservation Agents--pharmacology
Bone Neoplasms--drug therapy
Breast Neoplasms--drug therapy
Denosumab
Diphosphonates--pharmacology
Disease Progression
Disease-Free Survival
Female
Goserelin--therapeutic use
Humans
Imidazoles--therapeutic use
Male
Menopause
Neoplasms--drug therapy
Prostatic Neoplasms--drug therapy
Survival Rate
Treatment Outcome
Zoledronic Acid